We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Avinger Inc. (AVGR) Lowers Guidance, Stock Down 40%
Avinger Inc. (AVGR - Free Report) opened down 40% on Wednesday after announcing preliminary Q2 earnings and lowering their guidance.
The Redwood City, CA based firm designs, manufactures and sells image-guided catheter-based systems to treat peripheral arterial disease (PAD).
AVGR announced preliminary Q2 revenue of about $4.7 million, which although is a 57% year-over-year increase misses estimates by $1 million. According to the company’s official statement, revenues from disposable devices were $3.7 million, a 118% increase year-over-year, and a 12% increase from Q1 2016. However, revenue from their Lightbox imaging consoles is expected at $1 million, a 29% decrease year-over-year and a 17 % decrease from Q1 2016.
Along with the release of preliminary earnings, AVGR lowered its 2016 guidance. The company now expects revenue within the range of $19 million to $23 million (which represents year-over-year growth of 78% to 115%). This is down from the original guidance in the range of $25 million and $30 million.
Avinger currently sits at a Zacks Rank #3 (Hold).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>